270 related articles for article (PubMed ID: 24571058)
1. Review of high-dose intravenous vitamin C as an anticancer agent.
Wilson MK; Baguley BC; Wall C; Jameson MB; Findlay MP
Asia Pac J Clin Oncol; 2014 Mar; 10(1):22-37. PubMed ID: 24571058
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.
Duconge J; Miranda-Massari JR; Gonzalez MJ; Jackson JA; Warnock W; Riordan NH
P R Health Sci J; 2008 Mar; 27(1):7-19. PubMed ID: 18450228
[TBL] [Abstract][Full Text] [Related]
3. Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?
Cabanillas F
P R Health Sci J; 2010 Sep; 29(3):215-7. PubMed ID: 20799507
[TBL] [Abstract][Full Text] [Related]
4. [Vitamin C in complementary oncology--update 2009].
Gröber U
Med Monatsschr Pharm; 2009 Jul; 32(7):263-7. PubMed ID: 19731754
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C.
Eiselt J; Racek J; Opatrný K; Trefil L; Stehlík P
Blood Purif; 2006; 24(5-6):531-7. PubMed ID: 17077626
[TBL] [Abstract][Full Text] [Related]
6. [The impact of ascorbic acid on the concentrations of antioxidative vitamins in the plasma of patients with non-small cell lung cancer undergoing first-line chemotherapy].
Tokarski S; Rutkowski M; Godala M; Mejer A; Kowalski J
Pol Merkur Lekarski; 2013 Sep; 35(207):136-40. PubMed ID: 24224449
[TBL] [Abstract][Full Text] [Related]
7. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
Riordan HD; Casciari JJ; González MJ; Riordan NH; Miranda-Massari JR; Taylor P; Jackson JA
P R Health Sci J; 2005 Dec; 24(4):269-76. PubMed ID: 16570523
[TBL] [Abstract][Full Text] [Related]
8. Ascorbic acid and its pro-oxidant activity as a therapy for tumours of oral cavity -- a systematic review.
Putchala MC; Ramani P; Sherlin HJ; Premkumar P; Natesan A
Arch Oral Biol; 2013 Jun; 58(6):563-74. PubMed ID: 23477602
[TBL] [Abstract][Full Text] [Related]
9. High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.
Ohno S; Ohno Y; Suzuki N; Soma G; Inoue M
Anticancer Res; 2009 Mar; 29(3):809-15. PubMed ID: 19414313
[TBL] [Abstract][Full Text] [Related]
10. Vitamin C pharmacokinetics: implications for oral and intravenous use.
Padayatty SJ; Sun H; Wang Y; Riordan HD; Hewitt SM; Katz A; Wesley RA; Levine M
Ann Intern Med; 2004 Apr; 140(7):533-7. PubMed ID: 15068981
[TBL] [Abstract][Full Text] [Related]
11. High-dose intravenous vitamin C is not associated with an increase of pro-oxidative biomarkers.
Mühlhöfer A; Mrosek S; Schlegel B; Trommer W; Rozario F; Böhles H; Schremmer D; Zoller WG; Biesalski HK
Eur J Clin Nutr; 2004 Aug; 58(8):1151-8. PubMed ID: 15054428
[TBL] [Abstract][Full Text] [Related]
12. [Vitamin supplements in oncology -- necessary, useful or superfluous?].
Ritter E
MMW Fortschr Med; 2002 Oct; 144(41):33-7. PubMed ID: 12474358
[TBL] [Abstract][Full Text] [Related]
13. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.
Riordan HD; Riordan NH; Jackson JA; Casciari JJ; Hunninghake R; González MJ; Mora EM; Miranda-Massari JR; Rosario N; Rivera A
P R Health Sci J; 2004 Jun; 23(2):115-8. PubMed ID: 15377059
[TBL] [Abstract][Full Text] [Related]
14. High-Dose Vitamin C Injection to Cancer Patients May Promote Thrombosis Through Procoagulant Activation of Erythrocytes.
Kim K; Bae ON; Koh SH; Kang S; Lim KM; Noh JY; Shin S; Kim I; Chung JH
Toxicol Sci; 2015 Oct; 147(2):350-9. PubMed ID: 26139164
[TBL] [Abstract][Full Text] [Related]
15. Intravenously administered vitamin C as cancer therapy: three cases.
Padayatty SJ; Riordan HD; Hewitt SM; Katz A; Hoffer LJ; Levine M
CMAJ; 2006 Mar; 174(7):937-42. PubMed ID: 16567755
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.
Gordi T; Tan LH; Hong C; Hopkins NJ; Francom SF; Slatter JG; Antal EJ
J Clin Pharmacol; 2003 Oct; 43(10):1161-7. PubMed ID: 14517199
[TBL] [Abstract][Full Text] [Related]
18. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.
Creagan ET; Moertel CG; O'Fallon JR; Schutt AJ; O'Connell MJ; Rubin J; Frytak S
N Engl J Med; 1979 Sep; 301(13):687-90. PubMed ID: 384241
[TBL] [Abstract][Full Text] [Related]
19. Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.
Parrow NL; Leshin JA; Levine M
Antioxid Redox Signal; 2013 Dec; 19(17):2141-56. PubMed ID: 23621620
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.
Conner TA; McQuade C; Olp J; Pai AB
Biometals; 2012 Oct; 25(5):961-9. PubMed ID: 22706571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
